Supplements and Nutraceuticals: Perioperative Considerations

Published on 06/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2369 times

Advances in Anesthesia, Vol. 28, No. 1, ** **

ISSN: 0737-6146

doi: 10.1016/j.aan.2010.07.001

Herbal Supplements and Nutraceuticals: Perioperative Considerations

Herbal supplements and anesthesia

Herbal medicines have become enormously popular in recent years: nearly 20 million Americans are using herbal supplements for their purported health benefits including promotion of cardiac health, mental health, genitourinary health, and preventive health. These nutraceutical supplements are used in hopes of slowing the aging process, preventing the onset of dementia, lowering cholesterol, maintaining vision, enhancing immunity, and improving cardiovascular health. Society may be ingesting these supplements as an alternative to more expensive prescription drugs and as natural treatments with the goal of minimizing side effects that may accompany prescription medications. In 2007, Americans spent $34 billion on herbals and vitamins [1]. A recent survey revealed that the average person using supplements is older than 50 years, Caucasian, female, married, college-educated, and in a higher socioeconomic class [2].

Despite the common use of these agents, 70% of patients using these supplements neglect to tell their physician that they are taking them unless they are specifically asked. As a result, physicians may not be aware of potentially problematic substances and drug interactions of herbal medications with prescription drugs. Although these agents are often marketed as innocuous, the intake of these herbal medicines may pose health risks to patients.

The Dietary Health and Supplement Act of 1994 [3] defines herbal preparations as dietary supplements; therefore, they are not subject to the same rigorous safety and efficacy standards that prescription and over-the-counter medications must meet. For these supplements to be withdrawn from the market, the Food and Drug Administration (FDA) must prove a lack of safety [4].

Despite various salubrious effects of herbals, the possibility of detrimental side effects exists, especially when multiple supplements are used in combination. From 1985 to 1997, nearly 200 deaths were directly attributed to the use of herbal supplements [5]. Because the use of these dietary supplements is prevalent and increasing, an understanding of their possible interactions with commonly used anesthetic drugs as well as potential untoward effects is crucial for anesthesiologists and perioperative physicians.

Popular herbals that merit discussion include:

St John’s Wort

St John’s wort, derived from the flowering tops of the perennial plant Hypericum perforatum native to Europe and Asia, was brought to North America by European settlers. According to legend, the eponymous St John’s wort arose from the head of John the Baptist after his beheading. Patients may use this herb for its anxiolytic, sedative, bronchodilatory, and antidepressant effects, and as an analgesic for peptic ulcer disease and hemorrhoids [6]. Hyperforin and hypericin are believed to be 2 of the principal active constituents of St John’s wort responsible for its beneficial effects [7]. St John’s wort is available in a variety of preparations to treat various ailments. The suggested dose to treat depression is 300 mg, standardized to 0.3% hypericin, taken orally 3 times daily for 4 to 6 weeks; alternatively, a tea can be brewed from 2 to 4 g of the herb in 1 to 2 cups of water [7].

The mechanism of action of St John’s wort remains unknown, as in vitro and in vivo studies have reached different conclusions: in vitro studies demonstrate inhibition of monoamine oxidase isoforms, whereas in vivo studies demonstrate inhibition of γ-aminobutyric acid (GABA) receptors [8]. The antidepressant effects of the herbal may be a result of GABA inhibition. The potential for undesired side effects with concomitant administration of monoamine oxidase inhibitors (MAOIs), amphetamines, selective serotonin reuptake inhibitors (SSRIs), trazodone, tricyclic antidepressants, narcotics, and cold and flu medications exists [9]. Furthermore, St John’s wort has been implicated in one case of hypertensive crisis in a 41-year-old psychiatric patient [10].

Interactions with β-sympathomimetic agents such as Ma Huang or pseudoephedrine may instigate a hypertensive crisis. St John’s wort, when taken in combination with other SSRIs such as fluoxetine or paroxetine, may cause serotonergic syndrome, which is manifested by tremors, hyperthermia, autonomic dysfunction, hallucinations, myoclonus, and possibly death [11,13]. Photosensitivity is another common side effect of St John’s wort, therefore caution is advised when administering other drugs, such as tetracycline and piroxicam, which have similar adverse effects. In addition, caution is advised with patients concurrently using MAOIs. Further research is needed to elucidate the exact interactions and effects, but caution and awareness should be the rule in the perioperative period.

Echinacea

Echinacea is produced from the dried roots and rhizomes of the Echinacea angustifolia or Echinacea pallida plants. Fresh juice, made from the nonroot portions of the Echinacea purpurea plant, is also available [6]. Patients commonly take this herbal supplement to treat the following ailments: abscesses, eczema, burns, liver cancer [13], colorectal cancer [14], upper respiratory tract infections, urinary tract infections, varicose leg ulcers, and skin wounds [6].

The recommended dosage of echinacea is 6 to 9 mL of juice daily, or 900 to 1000 mg of powder orally 3 times daily, or 0.75 to 1.5 mL of tincture orally 2 to 5 times daily. In addition, echinacea can be brewed as a tea using 4 g of herb brewed in boiling water for 10 minutes. Using echinacea for 10 to 14 days is thought to provide maximal benefit; experts recommend taking this herb for no longer than 8 weeks, as the immune enhancing effects may be decreased by this time [6].

Certain patient populations may not benefit from echinacea therapy: individuals infected with human immunodeficiency virus, patients with AIDS, patients with collagen vascular disease, and patients suffering from multiple sclerosis (echinacea stimulates the immune system [14], therefore autoimmune diseases that are treated with immunosuppressant drugs may have a negative interaction with echinacea).

Echinacea is an inhibitor of the cytochrome P-450 3A4 hepatic microsomal system, one of the key metabolic enzyme pathways involved in drug metabolism. This effect can become a concern in patients concomitantly taking drugs that are metabolized by this system, including phenytoin, rifampin, rocuronium, and local anesthetics; caution is advised because there may be prolonged clinical effects of these agents [15]. Awareness of this interaction is important for anesthesia providers.

Ginkgo Biloba

Prized by Chinese herbalists for centuries, Western interest in ginkgo as a nonpharmacologic treatment of Alzheimer disease has intensified lately as more and more people have become interested in alternative medicines and therapies [16]. Ginkgo extract is derived from the leaves of the kew tree, also known as the maidenhair tree or Ginkgo biloba tree. Patients use Ginkgo to treat such ailments as asthma, dementia, hearing loss, SSRI-induced erectile dysfunction, memory loss, and senile macular degeneration, and to enhance alertness [6]. In France and Germany, ginkgo is among the leading prescriptions for poor circulation and dementia, whereas in the United States ginkgo is available only as an over-the-counter dietary supplement [6]. Ginkgo is among the most popular herbal supplements in the United States, with sales exceeding $150 million [17].

Commonly recommended dosages of ginkgo are, for dementia, 120 to 240 mg orally twice to thrice daily and for poor leg circulation, vertigo, or tinnitus, 120 to 160 mg orally twice to thrice daily [6].

Awareness of possible adverse effects of ginkgo is imperative for the anesthesiologist, as ginkgo is the third best-selling herbal product in the United States [15]. Although relatively safe, possible untoward effects of the herb include nausea, vomiting [18], headache, seizures, and increased risk of bleeding (the maximum recommended dose is 240 mg thrice a day). Furthermore, several case reports detailing morbidities of ginkgo exist: subarachnoid hemorrhage, subdural hematoma, and hyphema [1922]. The additive effects of ginkgo with aspirin, warfarin, enoxaparin, heparin, abciximab, and other anticoagulant and antiplatelet agents may contraindicate neuraxial anesthetic techniques, as clotting ability may be unpredictable. The terpene lactone components of ginkgo (ginkgolides) inhibit blood clotting via inhibition of platelet aggregation [21,23]. Perioperative physicians may better assess the degree to which a patient is anticoagulated using platelet function analysis and/or coagulation studies. Common drug interactions include a decreased efficacy of anticonvulsants when administered with ginkgo [23]. Also, the seizure threshold is lowered in patients taking tricyclic antidepressants with ginkgo [23]. It is recommended that gingko be discontinued 36 hours before surgery to decrease the risk of side effects [24].

Garlic

Garlic, botanically known as Allium sativum, is one of the most studied medicinal herbs. The use of garlic to treat various maladies has been traced back not only to the ancient China but also to western Europe [25]. Supplements of garlic are prepared from either dried cloves that have been crushed into powder or are made from garlic oil. Of note, products that claim to be “odor-free” may lack medicinal value, because it appears that the beneficial effects of garlic come from the sulfur-containing allicin, the chemical that imparts garlic with its distinctive aroma [6]. Garlic has been used to treat asthma, tinea pedis, constipation, diabetes, fungal infection, heavy-metal poisoning, hypertension, and hypercholesterolemia [6].

The commonly recommended dose of garlic for treating elevated cholesterol is 600 to 900 mg orally once daily [6]. Alternatively, 4 g of fresh garlic or 8 mg of garlic oil can be taken. The World Health Organization (WHO) 1999 monograph recommends these doses: 2 to 5 g fresh garlic, 0.4 to 1.2 g dried powder, 2 to 5 mg oil, 300 to 1000 mg extract, or any other formulation containing 2 to 5 mg allicin [6]. The formulation of garlic most often used in clinical trials is Kwai (Lichtwer Pharma, Köln, Germany); it is available as a nonenteric-coated dehydrated garlic powder formulation standardized for 1.3% allicin.

Garlic impairs platelet aggregation and has been associated with reports of bleeding. Based on this fact it should be used cautiously, if at all, in patients with peptic ulcer disease or intracranial bleeding, and in patients receiving concurrent antiplatelet or anticoagulation therapy or nonsteroidal anti-inflammatories, or with other drug-related hemostatic issues [26]. There is a case report of a spontaneous spinal/epidural hematoma in a patient using excessive amounts of garlic [27]. Other important adverse effects of garlic include dizziness, nausea, asthma exacerbations, hypothyroidism, and exacerbation of gastroesophageal reflux disease [6].

Garlic’s effect on platelet aggregation is complex and is caused by several mechanisms: garlic reduces thromboxane formation from arachidonic acid, inhibits phospholipase activity, and inhibits the incorporation of arachidonate into platelet phospholipids [28,29].

The anesthesiologist caring for patients being treated with garlic therapy should be especially cognizant for surgical hemostasis. Physicians should be vigilant perioperatively for the possibility of excessive bleeding both intra- and postoperatively [28]. Furthermore, garlic has been reported to interact with the P450 enzyme system [30], which also may affect concomitant drug metabolism.

Ginger

Although ginger, Zingiber officinale, has attractive purple-green flowers, herbalists value its root more than any other part of the plant. Ginger may be used to treat common ailments such as arthritis, motion sickness, nausea, muscle pain and swelling, and bacterial infections, due to its property as an antioxidant [6]. In addition, ginger has been demonstrated to be an effective cure for hyperemesis gravidarum in the obstetric population [31].

The dose of ginger depends on indication: the dose for nausea is powdered ginger 500 to 1000 mg orally, or fresh ginger root 1000 mg orally [6].

Despite the possible benefits of ginger therapy, certain concerns exist with the excessive intake of this agent. Ginger is a potent inhibitor of thromboxane synthetase. and may also interfere with platelet aggregation [32,33]; therefore, intake of ginger may increase bleeding time [34] and other tests that evaluate platelet function. In a patient with a history of bleeding or bruising, anesthesiologists should consider evaluating alteration in platelet function status before proceeding with a neuraxial or regional anesthetic technique. Ginger has been implicated as a source of arrhythmia, drowsiness, and excessive sedation, side effects of which perioperative physicians should be aware [6].

Ginseng

For over 2000 years, ginseng has been used in traditional Asian medicine to treat such ailments as depression, diabetes, hypertension, fluid retention, overactive thymus, and insomnia. Ginseng has also been used as an aphrodisiac, as a sedative, and to enhance the body’s stress response [6]. Commercially prepared American ginseng is extracted from the Panax quinquefolius plant, and Asian (Korean and Japanese) varieties are derived from the Panax ginseng plant. The Asian variety undergoes more post-harvest processing to isolate the extract and, because of this, it is more sought after for its medicinal properties. The recommended dose of ginseng is 0.5 to 2 g of dry ginseng root daily, or 200 to 600 mg of ginseng extract daily in 2 divided doses [6].

Ginseng has adaptogenic properties, augmenting adrenal steroid production via a central mechanism [35]. Hypoglycemic properties of ginseng are believed to be due to ginsenoside Rb2 and panaxans I, J, K, and L [3640]. Ginseng has been known to cause the following adverse effects: impotence, hypertension, chest pain, headache, blurred vision, epistaxis [41], insomnia, nausea, vomiting, nervousness, tachycardia, and vaginal bleeding.

Ginseng abuse syndrome is caused by the combination of ginseng with other stimulants, resulting in diarrhea, hypertension, restlessness, insomnia, depression, poor appetite, swelling, and unusual sense of well-being [6]. Ginseng, oral hypoglycemics, and insulin may interact synergistically [6]; blood glucose levels should be assessed perioperatively. The possibility of an acute manic episode exists when patients undergoing MAOI treatment use ginseng because of the additive effects of ginseng and the MAOIs [42,44]. For the anesthesiologist, it is important to be aware of the hypertensive effects of ginseng as well as its antiplatelet properties. Because many anesthetic agents themselves cause hemodynamic instability, the added variable of ginseng may make hemodynamic management challenging. It has been recommended that ginseng should be discontinued at least 1 week before surgery [45].

Siberian ginseng, Eleutherococcus senticosus, belonging to the same family as panax or Asian ginseng, is used as a treatment for inflammation and insomnia due to anxiety, and to improve exercise tolerance, regulate blood pressure, and stimulate the circulatory and immune systems. The recommended dose is 500 to 2000 mg orally, daily for no more than 3 weeks [6].

Possible adverse effects of Siberian ginseng include diarrhea, difficulty in concentrating, dizziness, hypertension, nervousness, and an unusual sense of well-being. Siberian ginseng has an adverse interaction with digoxin, barbiturates, and vitamins B1, B2, and C. Siberian ginseng, just as American and Asian ginseng, has a potent hypoglycemic effect [6]. Blood glucose levels should be ascertained before any procedure.

Ephedra (Ma Huang)

Ephedra is a herbal supplement that has been used in Chinese medicine to promote weight loss and to increase energy, and as a treatment for asthma and bronchitis [45]. Ephedra contains a combination of adrenergic alkaloids including ephedrine, pseudoephedrine, norephedrine, methylephedrine, and norpseudoephedrine [46]. Ephedrine is a noncatecholamine sympathomimetic agent with α-1, β-1, and β-2 activity acting at adrenergic receptors and releasing endogenous norepinephrine [45]. Patients chronically taking ephedra may be catecholamine depleted. Although ephedrine is safely administered by trained anesthesiologists intraoperatively as perioperative therapy for hypotension, unsupervised use by untrained laypersons is potentially dangerous because of the possibility of vasospasm of coronary and cerebral arteries and other sympathomimetic effects, including myocardial infarction and thrombotic stroke [47]. In addition, ephedra has been implicated in hypersensitivity myocarditis characterized by cardiomyopathy with lymphocytic and eosinophilic infiltrates [48]. The elimination half-life of ephedra is 5.2 hours, with 70% to 80% of the herb excreted unchanged in the urine; therefore, it should be discontinued at least 24 hours before surgery [49,50].

Although now of historical significance due to the sporadic use of halothane anesthesia, special consideration should be paid to patients undergoing halothane general anesthesia, because halothane sensitizes the myocardium to exogenous catecholamines, and ventricular arrhythmias may develop [51]. Theoretically, a similar concern exists in patients taking ephedra who receive high doses of desflurane and experience an increase in circulating catecholamines. Furthermore, long-term ephedra use results in tachyphylaxis of its sympathomimetic effects secondary to depletion of endogenous catecholamine stores, which may contribute to perioperative hemodynamic instability. Therefore, direct-acting sympathomimetics are the preferred agents to treat hypotension and bradycardia in these circumstances [45].

Despite the FDA ban on the sale of supplements containing ephedra, this supplement is reported as being readily available from various international Web sites [52].

Hoodia Gordonii

Tribesmen have traditionally used Hoodia gordonii, a cactus native to Southeastern Africa, during times of starvation to ease their hunger [53]. For the same reason, currently it is a popular weight loss supplement in the United States. Its pharmacologically active constituents include steroidal glycosides (P57AS3 or P57), and steroidal derivates: gordonosides, and calogenin glycosides [53]. MacLean and Luo [54] studied P57 isolated from hoodia, and determined in a rat model that cerebroventricular administration of P57 resulted in an increase in the adenosine triphosphate concentrations of hypothalamic neurons; this in turn was the hypothesized mechanism of appetite reduction. Human research is lacking, and there are few data concerning its efficacy or safety profile. P57 has also been shown to inhibit CYP3A4 activity, which may affect drug metabolism within the liver [55].

Green Tea

Green tea, Camellia sinensis, has been enjoyed in Asia for centuries and recently, green tea and its purified extract has been used in Western medicine as adjuvant treatment of obesity, hyperlipidemia, hypertension, and atherosclerosis [6]. Epigallocatechin-3-gallate (EGCG) is the principal active agent in green tea and is credited for providing an anticancer effect; it accounts for 40% of its total polyphenol content [56]. Other constituents of green tea that may affect the anesthetic management of patients include caffeine, theophylline, and proanthocyanidins (tannins) [57].

Specific doses of green tea to obtain maximal benefits have not been established, because most investigations have studied brewed green tea rather than an extract tablet (tablets vary from 100 to 750 mg of green tea extract) [58]. One cup of tea contains approximately 80 to 100 mg of polyphenols and approximately 50 mg of caffeine [58].

Most of the adverse effects of green tea are attributed to its caffeine content, therefore some experts recommend drinking decaffeinated green tea rather than green tea in its natural form. However, it is unknown whether decaffeinated tea has the same health benefits as natural green tea [59,60]. Caffeine is a central nervous system stimulant and a diuretic, increasing urine volume as well as urine sodium and potassium concentrations, thus potentially decreasing sodium and potassium concentrations in the blood. Furthermore, caffeine may worsen incontinence, may increase the production of stomach acid, and may exacerbate peptic ulcer symptoms [58]. Therefore, persons with concurrent advanced liver disease should use caffeine and green tea cautiously, as blood caffeine concentrations may accumulate [57]. In laboratory and animal studies, caffeine has been found to hinder blood clotting because it raises prothrombin time and partial thromboplastin time [58,59]. Furthermore, the tannins in green tea may reduce absorption and bioavailability of codeine, atropine, and iron supplements [44]. Use of green tea in infants has been associated with impaired iron metabolism and microcytic anemia [58]. Furthermore, the tannin content of green tea may inhibit the hemodynamic effects of adenosine [59].

Omega-3 Fatty Acids

Derived from either plant or fish sources, omega-3 polyunsaturated fatty acids are used primarily to treat elevated cholesterol levels. Typical dietary sources of these fatty acids include salmon, mackerel, sardines, albacore tuna, herring, soy, tofu, flax seed, walnuts, and canola oil. Because Alaskan and Greenland Inuits had favorable lipid profiles and a lower incidence of coronary artery disease as compared with non-Inuit cohorts, it was postulated that their diet, which is high in omega-3 fatty acids, was responsible for this difference. Subsequent studies addressing this fact demonstrated that people who ate fish weekly did in fact have lower mortality from coronary artery disease [61,62].

In the United States, 2 servings of fish per week is the current recommendation for people to reap the benefits of omega-3 fatty acids. It has been postulated that fish oils have several mechanisms of cardiac protection including antiarrhythmic effects, a reduction in serum triglyceride levels, decreased platelet aggregation, an anti-inflammatory effect via enhanced production of nitric oxide (endothelium-derived relaxing factor), and a modest decrease in blood pressure [63,64].

Although further study is necessary to validate these positive effects, many patients take fish oils for these perceived benefits, therefore knowledge of the effects of omega-3 oils is important for the anesthesiologist. Hemostasis can be an issue during surgery as well as planning for regional or neuraxial techniques. Coagulation studies should be obtained before any neuraxial or regional procedure in a patient who has a history of bleeding and bruising and concomitant use of omega-3 oils.

Kava Kava

Kava kava has been a popular beverage in the South Pacific for its ability to induce a tranquil, euphoric state and for its sociable effects [65]. Historically, women chewed the leaves, mixing the chewed leaves with coconut milk or other fruit juices [6]. For children diagnosed with attention-deficit/hyperactivity disorder a liquid extract is given orally (1:1 weight/volume fresh plant or 1:4 weight/volume dry plant) in a recommended dose of 5 to 15 drops diluted in their favorite beverage 2 to 3 times daily. The adult dose for anxiety is 100 to 250 mg 1 to 3 times per day as needed, standardized to contain 30% kavalactones per dose. When used solely as a sleep aid, 250 to 500 mg at bedtime is the recommended dose [6].

Kava kava may cause hallucinations, dermopathy, and visual changes [66,68]. Kava kava can also produce antinociceptive effects mediated through nonopioid-dependent pathways [69,70]. In addition, anesthesiologists should be aware that the use of kava kava may potentiate barbiturates and benzodiazepines, leading to excessive sedation [71].

Summary

Herbal medications are being used by the general population for various purported health benefits, including the treatment of cardiovascular, endocrine, psychiatric, and neurologic disorders [73] along with, and in addition to, prescription therapies. Patients may ingest these agents to treat maladies and health conditions “naturally.” Nutraceuticals, despite being derived from natural compounds, do have significant side effects and risks that have shown themselves in research studies [29], and may present some risk to patients. These possible side effects, coupled with a decreased regulation versus traditional prescription medicines, can lead to previously unanticipated consequences, including most commonly an increased risk of perioperative bleeding [74]. These side effects may occur with increased doses of the herbal medication and also with combination therapy with other nutraceuticals or prescription medicines. Because of the widespread use of these agents by patients, anesthesiologists as perioperative physicians must be aware of these agents and the risks they pose to their patients in the perioperative period (Tables 15).

Table 1 Herbals that may interfere with hemostasis

Garlic Decreases platelet aggregation
Ginkgo biloba Synergistic relationship with anticoagulants
Saw palmetto Potentiation of blood thinning agents. Some formulations of saw palmetto have been contaminated with coumadin [70]
Ginger Inhibits thromboxane synthetase and decreases platelet aggregation
Green tea Effects likely due to the caffeine content, raises prothrombin time and activated partial thromboplastin time
Fish oil Decreases platelet aggregation
Ginseng Decreases platelet aggregation

Table 2 Herbals causing excessive sedation

Kava kava Potentiates benzodiazepines and barbiturates
Ginger Used as a single agent may cause drowsiness
Valerian Potentiates sedatives and central nervous system depressants

Table 3 Herbals that may cause hemodynamic instability

St John’s wort Possibility of hypertensive crisis exists
Saw palmetto May elevate blood pressure
Ginger May cause arrhythmia
Ginseng May cause tachycardia. May cause falsely high or falsely low digoxin levels depending the assay used [67]. Discontinue 7 days before surgery
Siberian ginseng May elevate blood pressure. May cause falsely high or falsely low digoxin levels depending the assay used [71]
Ephedra Patients may be catecholamine depleted; direct-acting sympathomimetics are the preferred agents to treat hypotension and bradycardia
Green tea Tannin content renders atropine less effective [59]; adenosine less effective as well [43]
Fish oil May lower blood pressure
Valerian Possibility of arrhythmia exists

Table 4 Herbals interfering with the efficacy of other drugs

Echinacea Inhibitor of cytochrome P-450 3A4
Hoodia gordonii P57, the active constituent, is a potent inhibitor of cytochrome P-450 3A4
Ginkgo biloba May decrease the efficacy of anticonvulsants
Green tea The caffeine component decreases the efficacy of codeine

Table 5 Herbals affecting blood glucose levels

Ginseng Lowers glucose levels; evaluate glucose levels before surgery
Siberian ginseng Lowers glucose levels; evaluate glucose levels before surgery

References

[1] M. Marchione, M. Stobbe. Americans spend $34B for alternative medicine. Newsday (NY): The Associated press; July 31, 2009.

[2] R.A. Harrison, D. Holt, D.J. Pattison. Who and how many people are taking herbal supplements? A survey of 21,923 adults. Int J Vitam Nutr Res. 2004;74:183-186.

[3] Dietary Supplement Health and Education Act, 1994, PL 103-417 (180 Stat 2126).

[4] C. Marwick. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA. 1995;273:607.

[5] P.H. Tan, A.K. Chou, J.S. Peng. Accidental shock during epidural anesthesia in a patient with NSAID-induced hyporeninemic hypoalderosteronism. J Clin Anesth. 1997;9:424-427.

[6] Charles W Fetrow, Juan Avila. The complete guide to herbal medicines. New York: Simon and Schuster; 2000.

[7] Budavari Susan, editor. Merck index. 11th edition. Rahway (NJ): Merck and Co. 1989:4799.

[8] A. Kaye, R. Sabar, S. Vig, et al. Nutraceuticals—current concepts and the role of the anesthesiologist. Am J Anesthesiol. 2000;27(8):467-471.

[9] J.B. Gordon. SSRI and St. John’s wort: possible toxicity? Am Fam Physician. 1998;57:950-953.

[10] S. Patel, R. Robinson, M. Burk. Hypertensive crisis associated with St. John’s wort. Am J Med. 2002;112(6):507-508.

[11] J. Ness, ShermanFT, C.X. Pan. Alternative medicine: what the data say about the common herbal therapies. Geriatrics. 1999;54(10):33-43.

[12] J. Czekalla, M. Gastpar, W.D. Hübner, et al. The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine. Pharmacopsychiatry. 1997;30(Suppl 2):86-88.

[13] C. Lersch, M. Zeuner, A. Bauer. Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), echinacea purpurea extracts (echinacein), and thymostimulin. Arch Geschwulstforsch. 1990;60:379-383.

[14] C. Lersch, M. Zeuner, A. Bauer. Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and echinacea purpurea extract (echinacein) in patients with far advanced colorectal cancers. preliminary results. Cancer Invest. 1992;10:343-348.

[15] A. Kaye, R. Sabar, S. Vig, et al. Nutraceuticals—current concepts and the role of the anesthesiologist. Am J Anesthesiol. 2000;27(7):405-407.

[16] P.L. LeBars, M.M. Katz, N. Berman. A placebo controlled, double-blind randomized trial of an extract of gingko biloba for dementia. JAMA. 1997;278:1327-1332.

[17] M. Blumenthal. Herb sales down 3% in mass market retail stores. HerbalGram. 2000;49:68.

[18] M.H. Pittler, E. Ernst. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med. 2000;108(4):276-281.

[19] M. Rosenblatt, J. Mindel. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med. 1997;336:1108.

[20] J. Rowin, S.L. Lewis. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion have also occurred. Neurology. 1996;46:1775-1776.

[21] G.J. Gilbert. Ginkgo biloba. Neurology. 1997;48:1137.

[22] S. Vale. Subarachnoid hemorrhage associated with Ginkgo biloba. Lancet. 1998;352:36.

[23] L.G. Miller. Herbal medicinals. Arch Intern Med. 1998;158:2200-2211.

[24] Memorial Sloan Kettering Cancer Center. About herbs, botanicals, and other products. Available at: http://www.mskcc.org/mskcc/html/69235.cfm Accessed January 12, 2010

[25] L.D. Brace. Cardiovascular benefits of garlic (Allium sativum L). J Cardiovasc Nurs. 2002;16(4):33-49.

[26] H. Kiesewetter, F. Jung, E.M. Jung, et al. Effects of garlic coated tablets in peripheral arterial occlusive disease. Clin Investig. 1993;71(5):383-386.

[27] K.D. Rose, P.D. Croissant, C.F. Parliament, et al. Spontaneous epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery. 1990;26(5):880-881.

[28] A. Bordia. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis. 1978;30:355-360.

[29] M. LePoncin Lafitte, J. Rapin, J.R. Rapin, et al. Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats. Arch Int Pharmacodyn Ther. 1980;243:236-244.

[30] M.W. Krucoff, R. Costello, D. Mark, et al. Complementary and alternative medical therapy in cardiovascular care. In V. Fuster, R.A. O’Rourke, R.A. Walsh, et al, editors: Hurst’s the heart, 12th edition, NewYork: McGrawHill, 2007. Available at: http://www.accessmedicine.com.lp.hscl.ufl.edu/content.aspx?aID=3077596 Accessed January 12, 2010

[31] W. Fischer-Rasmussen, S.K. Kjaer, C. Dahl. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 1991;38(1):19-24.

[32] J.H. Guh, F.N. Ko, T.T. Jong, et al. Antiplatelet effect of gingerol isolated from Zingiber officinale. J Pharm Pharmacol. 1995;47(4):329-332.

[33] H.P. Wendel, W. Heller, M.J. Gallimore, et al. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement. Blood Coagul Fibrinolysis. 1993;4(1):41-45.

[34] J. Backon. Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry. Med Hypotheses. 1986;20:271-278.

[35] T.B. Ng, W.W. Li, H.W. Yeung. Effects of ginsenosides, lectins and Momordica charantia insulin like peptide on corticosterone production by isolated rat adrenal cells. J Ethnopharmacol. 1987;21:21-29.

[36] T. Yokozawa, T. Kobayashi, H. Oura, et al. Studies on the mechanism of hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chem Pharm Bull. 1895;33:869-872.

[37] Y. Oshima, C. Konno, H. Hikono. Isolation and hypoglycemic activity of panaxans I, J, K, and L, glycans of panax ginseng roots. J Ethnopharmacol. 1985;14:255-259.

[38] C. Konno, M. Murakami, O. Yoshiteru, et al. Isolation and hypoglycemic activity of panaxans Q, R, S, R, and U: glycans of panax ginseng roots. J Ethnopharmacol. 1985;14:69-74.

[39] C. Konno, M. Murakami, O. Yoshiteru, et al. Isolation and hypoglycemic activity of panaxans A, B, C, D, and E, glycans of panax ginseng roots. Planta Med. 1984;50:436-438.

[40] M. Tokmoda, K. Shimada, M. Konno, et al. Partial structure of Panax A: a hypoglycemic glycan of panax ginseng roots. Planta Med. 1984;50:436-438.

[41] T.G. Hammond, J.A. Whitworth. Adverse reactions to ginseng. Med J Aust. 1981;1:492.

[42] R.I. Shader, D.J. Greenblatt. Phenelzine and the dream machine ramblings and reflections. J Clin Psychopharmacol. 1985;5:65.

[43] B.D. Jones, A.M. Runikis. Interactions of ginseng with phenylzine. J Clin Psychopharmacol. 1987;7:201-202.

[44] F. Brinker. Herb contraindications and drug interactions, 3rd edition. Sandy (OR): Eclectic Medical Publications; 2001.

[45] M.K. Ang-Lee, J. Moss, C.S. Yuan. Herbal medicines and perioperative care. JAMA. 2001;286:208-216.

[46] B.J. Gurley, S.F. Gardner, M.A. Hubbard. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 2000;57:963-969.

[47] C.A. Haller, N.L. Benowitz. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838.

[48] S.M. Zaacks, L. Klein, C.D. Tan, et al. Hypersensitivity myocarditis associated with ephedra use. J Toxicol Clin Toxicol. 1999;37:485-489.

[49] L.M. White, S.F. Gardner, B.J. Gurley, et al. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol. 1997;37:116-122.

[50] B.J. Gurley, S.F. Gardner, L.M. White, et al. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang). Ther Drug Monit. 1998;20:439-445.

[51] M.F. Rozien. Anesthetic implications of concurrent diseases. In: R.D. Miller, editor. Anesthesia. 4th edition. New York: Churchill Livingstone Inc; 1994:903-1014.

[52] Ephedra for sale. Available at: http://www.supplementlifestyle.com/ Accessed February 23, 2010

[53] Memorial Sloan Kettering Cancer Center. About herbs, botanicals, and other products. Available at: http://www.mskcc.org/mskcc/html/69255.cfm Accessed July 10, 2009

[54] D.B. MacLean, L.G. Luo. Increased ATP content/production in the hypothalamus may be a signal for energy-sensing of satiety: studies of the anorectic mechanism of a plant steroidal glycoside. Brain Res. 2004;1020(1–2):1-11.

[55] V.L. Madgula, B. Avula, R.S. Pawar, et al. In vitro metabolic stability and intestinal transport of P57AS3 (P57) from Hoodia gordonii and its interaction with drug metabolizing enzymes. Planta Med. 2008;74(10):1269-1275.

[56] F. Tosetti, N. Ferrari, S. De Flora. Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J. 2002;16:2-14.

[57] Memorial Sloan Kettering Cancer Center. About herbs, botanicals, and other products. Available at: http://www.mskcc.org/mskcc/html/69247.cfm Accessed July 27, 2009

[58] Green tea (Camelia sinensis). Available at: http://www.mayoclinic.com/health/green-tea/NS_patient-green_tea Accessed July 27, 2009

[59] M.T. Huang, C.Y. Lee, C.T. Ho. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res. 1997;57:2623-2629.

[60] Memorial Sloan Kettering Cancer Center. About herbs, botanicals, and other products. Available at: http://www.mskcc.org/mskcc/html/69247.cfm Accessed March 22, 2010

[61] M.L. Burr, A.M. Fehily, J.F. Gilbert, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761.

[62] D. Kromhout, E.B. Bosschieter, C.C. de Lezenne. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.

[63] P. Marckmann, M. Gronbaek. Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur J Clin Nutr. 1999;53:585-590.

[64] C. Von Schacky, P. Angerer, W. Kothny. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554-562.

[65] J.A. Leak. Herbal medicine: Is it an alternative or an unknown? A brief review of popular herbals used by patients in a pain and symptom management practice setting. Curr Rev Pain. 1999;3:226-236.

[66] L.F. Garner, J.D. Klinger. Some visual effects caused by the beverage kava. J Ethnopharmacol. 1985;13(3):307-311.

[67] L.C. Winslow, D.J. Kroll. Herbs as medicines. Arch Intern Med. 1998;158:2192-2199.

[68] A. Dasgupta, M.A. Reyes. Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab fragment. Am J Clin Pathol. 2005;124(2):229-236.

[69] D.D. Jamleson, P.H. Duffield. The antinociceptive actions of kava components in mice. Clin Exp Pharmacol Physiol. 1990;17(7):495-507.

[70] Y.N. Singh. Effects of kava on neuromuscular transmission and muscular contractility. J Ethnopharmacol. 1983;7(3):267-276.

[71] J. Gruenwald, T. Brendler, C. Jaenicke, et al. PDR for herbal medicines, 1st edition. Montvale (NJ): Medical Economics Company; 1998. p.1043–5

[72] M.C. Carrasco, J.R. Vallejo, M. Pardo-de-Santayana, et al. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother Res. 2009;23(12):1795-1796.

[73] P.F. Smith, K. Maclennan, C.L. Darlington. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol. 1996;50:131-139.

[74] K.C. Srivastava. Evidence for the mechanism by which garlic inhibits platelet aggregation. Prostaglandins Leukot Med. 1986;22(3):313-321.